Session 3: Accelerating Drug Discovery and Personalized Treatment Using AI

Quick Overview

The research team developed a human-centered foundation model for cells, leveraging multi-modal data (sequence, structure, image, text) and AI to accelerate drug discovery and personalized treatment, with the RL-trained model (Biomni-R0) outperforming closed-source models like Claude 4 and GPT-5 on key biological benchmarks.

Key Points: The goal is to build a high-fidelity AI virtual cell model capable of simulating molecular building blocks (DNA, RNA, proteins) and their spatial organization. The project relies on four key data modalities: Sequence (DNA, RNA, protein), Structure, Image, and Text (literature), integrated via a unified AI virtual cell foundation model. Sequence models like UCE create a universal embedding space for 36 million cells across species and tissues, enabling zero-shot mapping of new data. Structure models, like HotPocketNN developed by Russ Altman's lab, identify ligand binding pockets on proteins, outperforming existing methods on challenging targets like KRAS. Image models (SubCell) use a multi-task learning framework to learn protein localization from Human Protein Atlas images, providing spatial context that sequence embeddings lack. The ultimate vision is an agentic future where AI automates biomedical research, augmenting biologists by providing the impact of an entire specialized team, rather than replacing them. The RL-trained Biomni-R0 model surpassed closed-source models like Claude 4 and GPT-5 on overall reward benchmarks, indicating significant progress toward expert-level performance in digital biology tasks.

Context: This presentation details a multi-disciplinary research effort led by PIs including Emma Lundberg, Jure Leskovec, Russ Altman, and Serena Yeung from Stanford University, focused on creating an AI-driven virtual cell model. The project aims to leverage massive, multi-modal biological data—including sequence, structure, image, and text—to accelerate drug discovery and personalized medicine by building models that understand the spatial and functional organization of cells.